LOWLIGHT
Home
OVER ONS
THERAPIE
ONDERZOEK
TRAINING
MEDIA
CONTACT
Home
ABOUT US
THERAPY
RESEARCH
TRAINING
MEDIA
CONTACT
NEURO LIGHT
GOAL
Evaluation of the efficacy of photobiomodulation (PBM) therapy in the management of chemotherapy-induced neuropathy.
STUDY DESIGN
Randomized pilot trial with patients diagnosed with chemotherapy-induced neuropathy.
This study started in February 2022.
Laser group 1 (n=15)
Laser group 2 (n=15)
PBM
(2x/week, for 3 weeks)
PBM
(2x/week, for 3 weeks)
Lasertherapy with a dosage of 6 J/cm²
Lasertherapy with a dosage of 8 J/cm²
STUDY RESULTS
Study is still active and no preliminary results are available.
PUBLICATIONS
PARTNERS
Home
OVER ONS
THERAPIE
ONDERZOEK
TRAINING
MEDIA
CONTACT
Home
ABOUT US
THERAPY
RESEARCH
TRAINING
MEDIA
CONTACT